TriSalus Life Sciences (TLSI) Preferred Dividend Payments (2023 - 2025)
TriSalus Life Sciences' (TLSI) quarterly Preferred Dividend Payments came in at $11.9 million in Q4 2025, up 1425.8% year-on-year from $783000.0 in Q4 2024, and down 35.48% quarter-over-quarter from $18.5 million in Q3 2025.
TriSalus Life Sciences (TLSI) Preferred Dividend Payments (2023 - 2025) Analysis & Trends
TriSalus Life Sciences' Preferred Dividend Payments history runs 3 years deep, the most recent figure standing at $11.9 million for Q4 2025.
- On a quarterly basis, Preferred Dividend Payments rose 1425.8% year-over-year to $11.9 million in Q4 2025; TTM through Mar 2026 was $31.2 million, a 1257.88% increase from a year earlier, with the FY2025 full-year figure at $11.9 million, up 274.75% from the prior year.
- Preferred Dividend Payments declined to $11.9 million in Q4 2025 per TLSI's latest filing, from $18.5 million in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $18.5 million in Q3 2025 and bottomed at $458000.0 in Q3 2023.
- The 3-year median for Preferred Dividend Payments is $800000.0 (2023), against an average of $3.9 million.
- Biggest YoY gain for Preferred Dividend Payments was 1425.8% in 2025; the steepest drop was 11.11% in 2025.
- Year by year, Preferred Dividend Payments stood at $800000.0 in 2023, then fell by 2.12% to $783000.0 in 2024, then surged by 1425.8% to $11.9 million in 2025.
- Per Business Quant, the three latest TLSI Preferred Dividend Payments figures stand at $11.9 million (Q4 2025), $18.5 million (Q3 2025), and $714000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | TriSalus Life Sciences | 220.07 Mn | 163.52 Mn | 7.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.95 Mn |
| Sep 30, 2025 | 18.52 Mn |
| Jun 30, 2025 | 714,000.00 |
| Mar 31, 2025 | 712,000.00 |
| Dec 31, 2024 | 783,000.00 |
| Jun 30, 2024 | 801,000.00 |
| Mar 31, 2024 | 801,000.00 |
| Dec 31, 2023 | 800,000.00 |
| Sep 30, 2023 | 458,000.00 |